medicines with semaglutide Novo Nordisk containing What to Know About Semaglutide:

Novo Nordisk) 6.0mg/mL solution for injection in pre-filled pens

Semaglutide is a GLP-1 receptor agonist that slows gastric emptying, reduces appetite, and increases feelings of fullness

This side effect is more commonly associated with males but can occur in females as well due to Spironolactones anti-androgenic effects

However, theres no clear causal link between GLP-1R agonism and severe depression or suicide

Diabesity: A Growing Metabolic Disease Burden Type 2 diabetes with obesity, commonly referred to as diabesity, is a highly prevalent metabolic condition characterized by insulin resistance, chronic hyperglycemia, and excess fat accumulation

This summers guidance to halt the medication for up to a week may not go far enough, either